Redmile as of Sept. 30, 2014
Portfolio Holdings for Redmile
Redmile holds 54 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Index option | 5.7 | $49M | 450k | 109.35 | |
| Valeant Pharmaceuticals Int | 5.0 | $44M | 333k | 131.20 | |
| Actavis | 4.6 | $40M | 164k | 241.28 | |
| Clovis Oncology | 4.1 | $36M | 785k | 45.36 | |
| Celgene Corporation | 4.0 | $35M | 369k | 94.78 | |
| Amicus Therapeutics (FOLD) | 3.9 | $34M | 5.7M | 5.95 | |
| McKesson Corporation (MCK) | 3.6 | $32M | 162k | 194.67 | |
| Chimerix (CMRX) | 3.6 | $31M | 1.1M | 27.62 | |
| Array BioPharma | 3.4 | $30M | 8.3M | 3.57 | |
| Receptos | 3.2 | $27M | 440k | 62.11 | |
| Trivascular Technologies | 3.0 | $26M | 1.8M | 14.58 | |
| Rite Aid Corporation | 2.9 | $26M | 5.3M | 4.84 | |
| Hca Holdings (HCA) | 2.7 | $23M | 328k | 70.52 | |
| Castlight Health | 2.5 | $22M | 1.7M | 12.94 | |
| Avalanche Biotechnologies In | 2.5 | $22M | 700k | 30.78 | |
| Mallinckrodt Pub | 2.4 | $21M | 231k | 90.15 | |
| Globus Med Inc cl a (GMED) | 2.2 | $19M | 966k | 19.67 | |
| Cubist Pharmaceuticals | 2.2 | $19M | 284k | 66.34 | |
| Zs Pharma | 2.1 | $19M | 474k | 39.23 | |
| NuVasive | 2.0 | $17M | 498k | 34.87 | |
| Healthways | 1.9 | $16M | 1.0M | 16.02 | |
| Oxford Immunotec Global | 1.9 | $16M | 1.1M | 15.27 | |
| Nanostring Technologies (NSTGQ) | 1.8 | $16M | 1.5M | 10.94 | |
| Health Net | 1.8 | $15M | 335k | 46.11 | |
| Model N (MODN) | 1.7 | $14M | 1.5M | 9.86 | |
| Insmed (INSM) | 1.6 | $14M | 1.1M | 13.05 | |
| Intra Cellular Therapies (ITCI) | 1.6 | $14M | 1.0M | 13.71 | |
| D Fluidigm Corp Del (LAB) | 1.6 | $14M | 560k | 24.50 | |
| WellCare Health Plans | 1.6 | $14M | 225k | 60.34 | |
| Universal Health Services (UHS) | 1.5 | $13M | 124k | 104.50 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $13M | 177k | 72.16 | |
| Puma Biotechnology (PBYI) | 1.4 | $12M | 51k | 238.57 | |
| Accuray Incorporated (ARAY) | 1.4 | $12M | 1.7M | 7.26 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.4 | $12M | 765k | 15.77 | |
| Civitas Solutions | 1.1 | $9.7M | 619k | 15.62 | |
| Kythera Biopharmaceuticals I | 1.1 | $9.2M | 282k | 32.76 | |
| Align Technology (ALGN) | 1.0 | $8.9M | 173k | 51.68 | |
| Cyberonics | 1.0 | $8.8M | 173k | 51.16 | |
| Cardiovascular Systems | 1.0 | $8.7M | 370k | 23.63 | |
| Flexion Therapeutics | 1.0 | $8.5M | 466k | 18.26 | |
| Loxo Oncology | 0.8 | $7.1M | 540k | 13.13 | |
| Achaogen | 0.8 | $6.9M | 770k | 8.96 | |
| Tokai Pharmaceuticals | 0.7 | $6.3M | 414k | 15.14 | |
| HMS Holdings | 0.7 | $5.7M | 304k | 18.85 | |
| Seattle Genetics | 0.6 | $4.8M | 128k | 37.18 | |
| Clovis Oncology | 0.5 | $4.5M | 100k | 45.36 | |
| eHealth (EHTH) | 0.5 | $4.3M | 178k | 24.13 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $3.0M | 49k | 61.34 | |
| Prothena (PRTA) | 0.3 | $2.8M | 126k | 22.16 | |
| Intercept Pharmaceuticals In | 0.1 | $524k | 2.2k | 236.89 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.1 | $452k | 1.7k | 273.61 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $413k | 6.5k | 63.54 | |
| Otonomy | 0.1 | $442k | 18k | 24.02 | |
| iShares Dow Jones US Health Care (IHF) | 0.0 | $289k | 2.7k | 107.04 |
